One of the most dire biomedical issues is the progress of techniques that increase the efficiency of vaccines. In a paper published on April 24, 2008 in the journal Vaccine, a Massachusetts's biotechnology company, Cure Lab, Inc. has projected law a new high tech* for anti-viral vaccination. This mechanization consists of two major elements. First, each vaccine antigen should be made in two forms.

More: - Continued here